X
‘Trojan horse’ cancer drug shows promise in multiple tumour types
https://pharmaphorum.com/news/trojan-horse-cancer-drug-shows-promise-multiple-tumour-types/
cancer research
Bayer and MD Anderson collaborate on novel targeted cancer treatments
Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
Taking up the gauntlet
A review of Cancer Research UK’s Grand Challenge awards programme for the latest cancer research projects.
AZ urges others to join genomic research consortium
Data gathered from Patient Derived Xenografts will aid drug and biomarker discovery.